In humans, the surgical removal of an ovary or ovaries is most often performed due to diseases such as ovarian cysts or cancer, or in conjunction with hysterectomy. In the … Continue Reading 3D-printed ovary bioprosthesis restores fertility in mice.
In a cancerous breast, researchers have seen the problems with the various components of breast tissue and could not fully explain why they happened. The tissue, called the stroma, includes … Continue Reading Human study identifies new gene as cause and early indicator of breast cancer.
A main barrier to immune therapy success has been the tumour’s ability to keep the immune system from functioning against the cancer. The immune cells are there, however, like an … Continue Reading Researchers use ‘demethylating’ precision medicine to fight cancer.
Thousands of women are living with ovarian cancer in Canada. It is estimated that this year, 2,800 Canadian women will be newly diagnosed with this disease. Even though ovarian cancer … Continue Reading Researchers discover new molecule responsible for ovarian cancer proliferation and drug resistance.
In a study involving more than 31,000 women with cancer-causing mutations in the BRCA1 or BRCA2 genes, researchers at The Basser Center for BRCA, the Abramson Cancer Center, and the … Continue Reading Large-scale study shows risk of breast and ovarian cancer differs by type of BRCA1, BRCA2 mutation.
Researchers at Oregon State University have developed a new way to selectively insert compounds into cancer cells, a system that will help surgeons identify malignant tissues and then, in combination … Continue Reading Nanotechnology guides cancer surgery and then selectively kills remaining malignant cells.
Researchers at the University of Connecticut have found a new way to identify protein mutations in cancer cells. The novel method is being used to develop precision medical vaccines to treat … Continue Reading Researchers develop first individualised precise medical vaccine for ovarian cancer.
Ovarian cancer is the most deadly gynecological cancer, claiming the lives of more than 50% of women who are diagnosed with the disease. A study involving the University of Ottawa … Continue Reading Researchers identify protein ‘protector’ of chemo-resistant ovarian cancer cells.
Over the years researchers have made tremendous strides in the understanding and treatment of cancer by searching genomes for links between genetic alterations and disease. Most of those studies have … Continue Reading Penn team mine specific ovarian cancer oncogene in ‘junk DNA’.
Scientists at A*STAR’s Institute of Medical Biology (IMB) have found new clues to early detection and precision treatment of ovarian cancer, currently one of the most difficult cancers to diagnose … Continue Reading A*STAR scientists make breakthroughs in ovarian cancer research.
Researchers with The Cancer Genome Atlas (TCGA) Research Network have completed the largest, most diverse tumour genetic analysis ever conducted, revealing a new approach to classifying cancers. The work, led … Continue Reading Largest-ever cancer genetic analysis reveals new way of classifying cancer.